Ibrutinib as salvage therapy in mantle cell lymphoma with central nervous system involvement in a pretreated unfit patient

Leuk Lymphoma. 2018 Jul;59(7):1734-1737. doi: 10.1080/10428194.2017.1387910. Epub 2017 Oct 11.

Affiliations

¹ a Department of Clinical Medicine and Surgery , Federico II University Medical School , Naples , Italy.
² b Clinical and Experimental Cytometry Unit , CEINGE - Biotecnologie Avanzate , Napoli , Italy.
³ c Advanced Biomedical Sciences , University of Naples 'Federico II' , Napoli , Italy.

PMID: 29019439
DOI: 10.1080/10428194.2017.1387910

No abstract available

Publication types

Letter

MeSH terms

Adenine / analogs & derivatives
Central Nervous System Neoplasms / diagnosis
Central Nervous System Neoplasms / drug therapy*
Central Nervous System Neoplasms / mortality
Central Nervous System Neoplasms / secondary*
Humans
Lymphoma, Mantle-Cell / pathology*
Magnetic Resonance Imaging
Piperidines
Protein Kinase Inhibitors / administration & dosage
Protein Kinase Inhibitors / adverse effects
Protein Kinase Inhibitors / therapeutic use*
Pyrazoles / administration & dosage
Pyrazoles / adverse effects
Pyrazoles / therapeutic use*
Pyrimidines / administration & dosage
Pyrimidines / adverse effects
Pyrimidines / therapeutic use*
Retreatment
Salvage Therapy
Treatment Outcome

Substances

Piperidines
Protein Kinase Inhibitors
Pyrazoles
Pyrimidines
ibrutinib
Adenine